Literature DB >> 16526555

Physicochemical and pharmacokinetic characteristics of cationic liposomes.

W Yeeprae1, S Kawakami, S Suzuki, F Yamashita, M Hashida.   

Abstract

After intravenous administration of plasmid DNA (pDNA)/cationic liposome complexes, the gene expression is predominantly observed in the lung due to the physicochemical properties of the liposome complexes and the physiology of the lung. To determine the physicochemical properties and distribution behavior of cationic liposomes for lung-selective drug and/or gene delivery systems, N-[1-(2,3-dioleyloxy)propyl]-n,n,n-trimethylammonium chloride (DOTMA)/cholesterol and 1,2-dioleoyl-3-trimethyl-ammoniopropane (DOTAP)/cholesterol liposomes were studied. The particle sizes of DOTMA/cholesterol and DOTAP/cholesterol liposomes were very similar: 126 and 128 nm, respectively. Furthermore, the zeta potentials of these two liposomes were 51 and 66 mV, respectively. After intravenous injection into mice, both cationic liposomes were rapidly eliminated from the blood circulation and preferentially recovered in the lung. Interestingly, the highest lung accumulation was observed at 1 min, and then, decreased gradually. The distribution characteristics of DOTMA/cholesterol and DOTAP/cholesterol liposomes were almost identical due to the similarities in their physicochemical properties. These results demonstrated that DOTMA/cholesterol and DOTAP/cholesterol liposomes, which possess a positive charge, are promising carriers for lung-selective drug and/or gene delivery systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16526555

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  5 in total

1.  Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats.

Authors:  Susanne Herber-Jonat; Rashmi Mittal; Stefan Gsinn; Hermann Bohnenkamp; Eric Guenzi; Andreas Schulze
Journal:  Inflamm Res       Date:  2010-10-12       Impact factor: 4.575

2.  Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.

Authors:  Mingqian Tan; Zhen Ye; Daniel Lindner; Susann M Brady-Kalnay; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2013-03-08       Impact factor: 4.200

3.  Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.

Authors:  Birgit Romberg; Christien Oussoren; Cor J Snel; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

4.  Gene delivery into hepatic cells with ternary complexes of plasmid DNA, cationic liposomes and apolipoprotein E-derived peptide.

Authors:  Yoshiyuki Hattori; Yuta Nakagawa; Hiraku Onishi
Journal:  Exp Ther Med       Date:  2019-08-07       Impact factor: 2.447

5.  Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Fredric Kaye; Parvesh Sharma; Brij M Moudgil; William L Clapp; Najmunnisa Nasreen
Journal:  Int J Nanomedicine       Date:  2013-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.